Revolution Medicines Inc
NASDAQ:RVMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revolution Medicines Inc
NASDAQ:RVMD
|
US |
|
Odyssey Gold Ltd
F:ODQ
|
AU |
|
C
|
Central Plains Bancshares Inc
NASDAQ:CPBI
|
US |
|
H
|
Heartland Group Holdings Ltd
ASX:HGH
|
NZ |
|
Anson Resources Ltd
ASX:ASN
|
AU |
|
S
|
SPC Power Corp
XPHS:SPC
|
PH |
|
Energy of Minas Gerais Co
F:CIDA
|
BR |
|
H
|
Heartland Group Holdings Ltd
F:73X
|
NZ |
Intrinsic Value
Is RVMD undervalued or overvalued?
See the intrinsic value estimate for Revolution Medicines Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Revolution Medicines Does
Revolution Medicines is a biotechnology company that develops cancer drugs aimed at one of the hardest drug targets in oncology: the RAS signaling pathway. Its lead programs are designed to block specific RAS mutations, especially those found in tumors such as pancreatic, lung, and colorectal cancers. The company does not sell consumer products; it is building prescription medicines that oncologists would use in hospital and clinic settings.
- Headquarters
- United States of America US
- Employees
- 883
- IPO date
- Feb 13, 2020
Revolution Medicines has no economic moat
Protecting a particular medicine does not prevent other companies from developing different treatments for the same cancers. Revolution Medicines faces competing drug developers, without an established production-cost advantage that rivals cannot match.
Read the full moat analysis
Earnings Waterfall
Revolution Medicines Inc
The intrinsic value for Revolution Medicines Inc (RVMD) under the Base Case is hidden USD.
Compared with the current market price of 188.85 USD, the stock appears hidden.